Dorothy J Rodriguez

age ~52

from Ocala, FL

Get Report

Connected to:

Dorothy Rodriguez Phones & Addresses

Ocala, FL
Saint Petersburg, FL
Cold Spring, NY
526 40Th St APT 1R, Brooklyn, NY 11232 • 3477213422
Orlando, FL
Little Neck, NY
Franklin Square, NY

Work

Company:

House cleaning services
Nov 2007
Position:

Housekeeping

Education

School / High School:

Brandon High School
May 1998
Specialities:

Marketing

Resumes

Dorothy Rodriguez Gibsonton, FL

view source

Work:

House Cleaning Services

Nov 2007 to Present
Housekeeping Rooms-To-Go
Brandon, FL
Jun 2005 to Nov 2007
Receptionist Home Depot
Tampa, FL
Sep 2002 to Mar 2005
Customer Service Representative Mini Vacation
Tampa, FL
Feb 2000 to Dec 2001
Sales Representative

Education:

Brandon High School
May 1998
Marketing

Name / Title

Company / Classification

Phones & Addresses

Dorothy Rodriguez
Secretary

All D's Corp

431 Eagle Dr, Kissimmee, FL 34759

Us Patents

Method And Composition For Inhibition Of Angiogenesis Using Antagonists Based On Mmp-9 And Β1 Integrins
view source
US Patent:

7101975, Sep 5, 2006
Filed:

Jul 13, 2000
Appl. No.:

09/615624
Inventors:

Peter C. Brooks - West Harrison NY, US
Dorothy Rodriguez - West Harrison NY, US
Assignee:

University of Southern California - Los Angeles CA
International Classification:

C07K 16/00
A61K 38/00
US Classification:

5303871, 5303877, 5303881, 530300
Abstract:

Antagonists for modifying protein-protein interactions involving certain amino acid sequences within MMP-9 and/or β1 integrins are described. Such antagonists inhibit angiogenesis, tumor growth and disease states. Example antagonists are polypeptide and non-polypeptide molecules, including the novel antibody Mab FM155 and the novel synthetic peptide FRIP-1. Methods for inhibiting angiogenesis and disease states by administering such antagonists are disclosed. Methods for identifying antagonists that modify protein-protein interactions involving certain amino acid sequences within MMP-9 and/or β1 integrins are also described.

Method And Composition For Inhibition Of Angiogenesis Using Antagonists Based On Mmp-9 And Β1 Integrins
view source
US Patent:

7566449, Jul 28, 2009
Filed:

Mar 25, 2005
Appl. No.:

11/089999
Inventors:

Peter C. Brooks - West Harrison NY, US
Dorothy Rodriguez - West Harrison NY, US
Assignee:

University of Southern California - Los Angeles CA
International Classification:

A61K 39/395
US Classification:

4241301
Abstract:

Antagonists for modifying protein-protein interactions involving certain amino acid sequences within MMP-9 and/or β1 integrins are described. Such antagonists inhibit angiogenesis, tumor growth and disease states. Example antagonists are polypeptide and non-polypeptide molecules, including the novel antibody Mab FM155 and the novel synthetic peptide FRIP-1. Methods for inhibiting angiogenesis and disease states by administering such antagonists are disclosed. Methods for identifying antagonists that modify protein-protein interactions involving certain amino acid sequences within MMP-9 and/or β1 integrins are also described.

Inhibition Of Melanogenesis And Melanoma Metastasis With P-Aminobenzoic Acid (Paba)
view source
US Patent:

7691905, Apr 6, 2010
Filed:

Dec 23, 2003
Appl. No.:

10/746206
Inventors:

Peter C. Brooks - Carmel NY, US
Danielle Morais - Bedford Hills NY, US
Dorothy Rodriguez - Pequannock NJ, US
Assignee:

New York University - New York NY
International Classification:

A61K 31/192
US Classification:

514557
Abstract:

The present invention relates to the inhibition of melanogenesis with para-aminobenzoic acid (PABA) and its use in treating melanotic cancer.

Novel Method And Composition For Inhibition Of Angiogenesis And Tumor Growth Using Compounds Based On A Sequence Within Mmp-2
view source
US Patent:

20020182215, Dec 5, 2002
Filed:

Jun 1, 2001
Appl. No.:

09/872165
Inventors:

Peter Brooks - West Harrison NY, US
Dorothy Rodriguez - West Harrison NY, US
International Classification:

A61K048/00
A61K039/395
A61K038/48
C12N009/99
C07K016/30
US Classification:

424/155100, 424/094100, 514/044000, 435/184000, 530/388800
Abstract:

The present invention provides methods and compositions for inhibiting angiogenesis, tumor growth and treating disease states using a peptide that contains a specific amino acid sequence of matrix metalloproteinase 2 (MMP-2). In one embodiment, the invention provides a peptide, which comprises the amino acid sequence Ile-Phe-Ala-Gly-Asp-Lys-Phe-Trp-Arg, preferably flanked by cysteine residues at the amino and carboxy termini. Additionally, the invention provides compositions for inhibiting angiogenesis or tumor growth or for treating disease states comprising organic and non-peptidic mimetics based on the above amino acid sequence as well as optimized sequences flanking the region of MMP-2 within which the sequence lies. Also provided are methods for detecting angiogenesis, tumorous tissue, metastases, and tumor invasion into a tissue by contacting a composition of the invention with a tissue and methods for screening compositions of the invention.

Inhibition Of Melanogenesis And Melanoma Metastasis With P-Amino Benzoic Acid (Paba)
view source
US Patent:

20100323002, Dec 23, 2010
Filed:

Feb 5, 2010
Appl. No.:

12/701093
Inventors:

Peter C. Brooks - Carmel NY, US
Danielle Morais - Bedford Hills NY, US
Dorothy Rodriguez - Pequannock NJ, US
Assignee:

NEW YORK UNIVERSITY - New York NY
International Classification:

A61K 31/196
A61P 35/00
A61K 31/337
A61K 38/14
A61K 31/675
A61K 31/282
A61K 31/366
A61K 31/4745
A61K 31/198
A61K 31/704
A61K 9/127
A61K 31/69
A61K 38/21
A61K 31/7088
A61K 31/7068
A61K 39/395
A61K 38/20
A61K 38/19
A61K 31/496
A61K 31/4196
A61K 31/661
A61K 31/5685
A61K 31/4188
A61K 33/36
A61P 35/04
US Classification:

424450, 514567, 514449, 514 193, 514110, 514492, 514463, 514283, 514564, 514 34, 514 64, 424 857, 514 44 A, 514 49, 4241331, 424 852, 424 851, 51425218, 514383, 514114, 514171, 514393, 424623
Abstract:

The present invention relates to the inhibition of melanogenesis with para-aminobenzoic acid (PABA) and its use in treating melanotic cancer.